Probably of more significance and controversy is the contention that the biologic plausibility of immune system involvement in the pathogenesis of MCS is suspect. The lack of consistent physical findings or laboratory evidence of systemic inflammation argues against an autoimmune basis for MCS. Moreover, a principal characteristic of the immune system is its specificity, and therefore immune system dysfunction is unlikely to account for the spreading phenomenon described by MCS patients. There also is little evidence of immune system dysfunction in terms of an MCS association with autoimmune disease, increase in opportunistic infections, increase in cancer risk, or even relationship to atopy. At best, some of these immune markers may be identified as biomarkers of exposure and this would also require carefully designed studies with rigorous attention to laboratory methods and exposure assessment. Unfortunately, by focusing interest on the immune system, this and similar reports have overlooked other components of host defense such as direct irritant responses and neurogenic inflammation even though they provide a potential biologic basis for components of the MCS symptomatology.
